Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion type Assertion NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_head.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion description "[The A3669G polymorphism, which stabilizes GR? mRNA, had greater frequency in PV (55%; n = 22; P = .0028) and myelofibrosis (35%; n = 20) patients than in NDs (9%; n = 22) or patients with essential thrombocythemia (6%; n = 15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_provenance.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion evidence source_evidence_literature NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_provenance.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion SIO_000772 21355091 NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_provenance.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion wasDerivedFrom befree-20140225 NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_provenance.
- NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_assertion wasGeneratedBy ECO_0000203 NP929828.RAadTC3ZVKjnmKctrW0FRw-QBA9hP4aZsyfq5ZrY-mu8s130_provenance.